Abstract:To the Editor We read with great interest the recent article entitled “Fluorescent‐ guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent‐guided surgery in colorectal and pancreatic cancer” by Vuijk et al. This study foresaw a bright future for tumor‐specific imaging and staging strategy. The rationale for carcinoembryonic antigen (CEA) targeted imaging lies in (a) CEA highly expressed on tumour types and it was unaffected by neoadjuvant therapy, (b) anti‐CEA chimerized monoclonal antibody conjugated fluorochrome outperformed normal fluorescent reagents by molecular structure and diagnostic efficiency, and (c) safe tolerability and pharmacokinetics. The author overviewed preclinical and clinical studies and emphasized that the CEA targeted fluorescence were able to demarcate tumor nodules that could not be visualized in conventional bright light surgery. However, a very high tumor‐to‐background ratio measured ex vivo vs in vivo, and a certain extent of autofluorescence and background scattering previously described in fluorescence imaging studies potentially hinted a need for more sensitive intraoperative imaging systems. For colorectal cancer: Serum CEA levels were reported to be inadequate for rectal cancer patient selection because of a lack of correlation between tumor CEA expression and serum CEA levels. Preoperative cT staging assessment has always been a suitable and valid standard of patient selection. For pancreatic cancer: Disadvantageous CEA loss expression after neoadjuvant treatment was seen in pancreatic ductal adenocarcinoma. Serum CEA levels seem to be accurate to predict CEA tumor expression for fluorescence imaging surgery and posthospital follow up without a history of neoadjuvant treatment. For gastric cancer: Complicated lymphatic drainage and completely obliterated lymph channels (or nodes) have always been challenging for fluorescence imaging using indocyanine green (ICG) or ICG:NanoColl, underlining an urgent need for tumor‐specific fluorescent tracers for gastric cancer. The author foresaw a bright future for tumor‐specific imaging for gastric cancer. Whereas, the author was not sure if there exists a tumor‐targeted reagent that will wondrously outmatch pathological detection. In addition, what we especially want to propose is that a fluorescence imaging is just a macroscopic optical imaging, although it is combined with tumor‐specific regents in molecular level. To date, pathological testing remains a gold reference to discriminate cytological malignancy. Pathology molecular diagnostic techniques, such as reverse transcription‐polymerase chain reaction and one‐step nucleic acid amplification, have emerged as rapid, real‐time, and sensitive tools to detect lymph node micrometastasis. However, the time required to obtain results is still too long for use in the intraoperative diagnosis, and more studies are needed to improve these molecular tools. Therefore, future perspectives and expectations should look forward to tumor specific fluorescence imaging and these evolving and innovative pathological diagnosis techniques as well.

Successful Fluorescence-Guided Surgery on Human Colon Cancer Patient-Derived Orthotopic Xenograft Mouse Models Using a Fluorophore-Conjugated Anti-Cea Antibody and a Portable Imaging System.

[Echography in the study of periskeletal soft tissues: technique, normal and pathologic pictures].

Rapid tumor‐labeling kinetics with a site‐specific near‐infrared anti‐CEA nanobody in a patient‐derived orthotopic xenograft mouse model of colon cancer

Excessive Expectations for Carcinoembryonic Antigen Targeted Fluorescent‐guided Surgery for Sentinel Lymph Node Detection in Colorectal, Pancreatic, and Gastric Cancer

Stable expression of recombinant human alpha3/4 fucosyltransferase III in Spodoptera frugiperda Sf9 cells.

Precise navigation surgery of tumours in the lung in mouse models enabled by in situ fluorescence labelling with a killer-reporter adenovirus

Development of a plant‐based surgical training model for fluorescence‐guided cancer surgery

[The significance and expresssion of fractalkine in acute rejection after rat orthotopic liver transplantation].

Human Serum Albumin Decorated Indocyanine Green Improves Fluorescence-Guided Resection of Residual Lesions of Breast Cancer in Mice

Intraoperative Guidance of Pancreatic Cancer Resection Using a Toll-like Receptor 2-Targeted Fluorescence Molecular Imaging Agent

Topical Ph Sensing NIR Fluorophores for Intraoperative Imaging and Surgery of Disseminated Ovarian Cancer.

A pan-cancer agent for screening, resection and wound monitoring via NIR and SWIR imaging

Multimodal CEA-targeted fluorescence and radioguided cytoreductive surgery for peritoneal metastases of colorectal origin

Detection of Micrometastases Using SPECT/Fluorescence Dual-Modality Imaging in a CEA-Expressing Tumor Model

A superficial colon tumor model involving subcutaneous colon translocation and orthotopic transplantation of green fluorescent protein-expressing human colon tumor

Monoclonal Antibodies for Targeted Fluorescence-Guided Surgery: A Review of Applicability across Multiple Solid Tumors

Fuel homeostasis during physical inactivity induced by bed rest.

High-precision detection and navigation surgery of colorectal cancer micrometastases

Fluorescence-guided nodal navigation during colectomy for colorectal cancer

Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe

Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore